Compensated liver disease Completed Phase 2 Trials for Ombitasvir (DB09296)

Also known as: Compensated Cirrhosis / Liver Cirrhosis / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0020249 (Compensated liver disease)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01995071A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)Treatment